. Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?. Neurotherapeutics. 2018 Oct;15(4):1032-1035. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.